PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
11-Feb-2020 Stilla Technologies raises EUR20 million ($22 million) in Series B round that brings in new investor, TUS-Holdings, alongside existing ones Stilla Technologies
11-Feb-2020 AbbVie to Present at the SVB Leerink 9th Annual Global Healthcare Conference AbbVie
11-Feb-2020 BD Completes Clinical Trial for BD Libertas™ Wearable Injector B3C newswire
11-Feb-2020 Medivir Invites to R&D Day on March 2, 2020 Medivir
10-Feb-2020 Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2020 Ended December 31, 2019 and Provides Conference Call Information Elite Pharmaceuticals, Inc.
10-Feb-2020 Seattle Genetics and Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV(TM) (enfortumab vedotin-ejfv) in Combination with Immune Therapy Pembrolizumab as Investigational First-Line Treatment for Advanced Bladder Cancer Astellas
10-Feb-2020 Janssen Announces Submission to U.S. FDA for New DARZALEX® (Daratumumab)-Based Combination Regimen for Patients with Relapsed/Refractory Multiple Myeloma Janssen Oncology
10-Feb-2020 Protalix BioTherapeutics Presents Key Clinical Data of Pegunigalsidase Alfa for the Treatment of Fabry Disease at the 16th Annual WORLDSymposium(TM) 2020 Protalix BioTherapeutics, Inc.
10-Feb-2020 Halozyme To Host Fourth Quarter And Full Year 2019 Financial Results Webcast And Conference Call Halozyme Therapeutics, Inc.
10-Feb-2020 HumanOptics AG: Correction of the expected earnings forecast for the current financial year 2019/2020 HumanOptics AG
10-Feb-2020 CO.DON AG adds contract manufacturing to its product portfolio CO.DON AG
10-Feb-2020 4basebio AG: 4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares (news with additional features) 4basebio AG
10-Feb-2020 4basebio AG: 4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares 4basebio AG
10-Feb-2020 Lilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study Eli Lilly and Company
10-Feb-2020 GenScript ProBio Screens anti-2019 nCoV Antibodies in Just 24 Hours GenScript Biotech Corporation
10-Feb-2020 Valeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain Employees Valeritas Holdings, Inc.
07-Feb-2020 FDA Expertise Advancing the Understanding of Intentional Genomic Alterations in Animals U.S. Food and Drug Administration
07-Feb-2020 SUNFISH Pivotal Results for Risdiplam (RG7916) Demonstrate Medically Meaningful Benefit in Broadest Age Group of Patients Studied with Type 2 and 3 Spinal Muscular Atrophy PTC Therapeutics, Inc.
07-Feb-2020 Inceptua and Portola enter exclusive distribution agreement for Ondexxya® Inceptua
07-Feb-2020 Chi-Med Announces the Exercise of Underwriters’ Over-allotment Option for Public Offering of ADSs Chi-Med